Literature DB >> 17229855

Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens.

Véronique Fontaine1, Corinne Mascaux, Christine Weyn, Aurore Bernis, Nathalie Celio, Philippe Lefèvre, Leonard Kaufman, Christian Garbar.   

Abstract

A strategy combining human papillomavirus general primer (mainly the PGMY primers)-directed PCR sequencing and type-specific PCR is presented. DNA samples were first tested in general primer-mediated PCR. The amplified fragments of positive samples after ethidium bromide-stained DNA gel analysis were further sequenced, and corresponding DNA samples were further analyzed by PCR using type-specific primers for human papillomavirus (HPV) types 16, 18, 31, and 52. The comparison of the results of 157 samples analyzed by this strategy in parallel with the Hybrid Capture 2 tests and with the HPV INNO-LiPA (Innogenetics line probe assay) shows that this method is suitable for HPV detection and genotyping in cervical cell samples. Although the PCR sequencing method is as sensitive as the HPV INNO-LiPA for HPV detection, our method allows the identification of a broader range of HPV types. In contrast, the HPV INNO-LiPA was less time-consuming and better identified coinfections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229855      PMCID: PMC1829119          DOI: 10.1128/JCM.02098-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91.

Authors:  Masanori Terai; Robert D Burk
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

Review 3.  The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.

Authors:  Evangelos Paraskevaidis; Marc Arbyn; Alexandros Sotiriadis; Emmanuel Diakomanolis; Pierre Martin-Hirsch; George Koliopoulos; George Makrydimas; Jovan Tofoski; Dimitrios H Roukos
Journal:  Cancer Treat Rev       Date:  2004-04       Impact factor: 12.111

4.  Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.

Authors:  François Coutlée; Patti Gravitt; Janet Kornegay; Catherine Hankins; Harriet Richardson; Normand Lapointe; Hélène Voyer; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 5.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

6.  Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.

Authors:  B Kleter; L J van Doorn; L Schrauwen; A Molijn; S Sastrowijoto; J ter Schegget; J Lindeman; B ter Harmsel; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Authors:  F Karlsen; M Kalantari; A Jenkins; E Pettersen; G Kristensen; R Holm; B Johansson; B Hagmar
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

8.  Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy.

Authors:  S Y Chan; H Delius; A L Halpern; H U Bernard
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.

Authors:  G Denise Zielinski; Lawrence Rozendaal; Feja J Voorhorst; Johannus Berkhof; Peter J F Snijders; Elle J K Risse; Arnold P Runsink; Frits A de Schipper; Chris J L M Meijer
Journal:  Gynecol Oncol       Date:  2003-10       Impact factor: 5.482

10.  Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project.

Authors:  Ritu Nayar; Diane Solomon
Journal:  Cytojournal       Date:  2004-10-21       Impact factor: 2.091

View more
  15 in total

1.  Evidence of human papillomavirus in the placenta.

Authors:  Christine Weyn; Dominique Thomas; Jacques Jani; Meriem Guizani; Cathérine Donner; Michel Van Rysselberge; Christine Hans; Michel Bossens; Yvon Englert; Véronique Fontaine
Journal:  J Infect Dis       Date:  2010-12-14       Impact factor: 5.226

2.  High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.

Authors:  Jeffrey C Liu; Shobha Parajuli; Elizabeth Blackman; Denise Gibbs; Ashley Ellis; Anna Hull; J Robert Beck; Veda Giri; Patrick Iherjirka; Jasvir S Khurana; Camille R Ragin
Journal:  Head Neck       Date:  2015-07-18       Impact factor: 3.147

3.  Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.

Authors:  Vanessa Deschoolmeester; Veerle Van Marck; Marc Baay; Christine Weyn; Peter Vermeulen; Eric Van Marck; Filip Lardon; Veronique Fontaine; Jan B Vermorken
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

4.  Distribution of human papillomavirus genotypes in sardinian patients with oral squamous cell carcinoma.

Authors:  Caterina Montaldo; Andrea Mastinu; Stefania Zorco; Noemi Santini; Elisabetta Pisano; Vincenzo Piras; Gloria Denotti; Carla Peluffo; Matteo Erriu; Valentino Garau; Germano Orrù
Journal:  Open Virol J       Date:  2010-07-13

5.  Emergence of infectious malignant thrombocytopenia in Japanese macaques (Macaca fuscata) by SRV-4 after transmission to a novel host.

Authors:  Munehiro Okamoto; Takayuki Miyazawa; Shigeru Morikawa; Fumiko Ono; Shota Nakamura; Eiji Sato; Tomoyuki Yoshida; Rokusuke Yoshikawa; Kouji Sakai; Tetsuya Mizutani; Noriyo Nagata; Jun-ichiro Takano; Sachi Okabayashi; Masataka Hamano; Koji Fujimoto; Takaaki Nakaya; Tetsuya Iida; Toshihiro Horii; Takako Miyabe-Nishiwaki; Akino Watanabe; Akihisa Kaneko; Akatsuki Saito; Atsushi Matsui; Toshiyuki Hayakawa; Juri Suzuki; Hirofumi Akari; Tetsuro Matsuzawa; Hirohisa Hirai
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

6.  Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland.

Authors:  John F Menton; Suzanne M Cremin; Lydie Canier; Mary Horgan; Liam J Fanning
Journal:  Virol J       Date:  2009-07-23       Impact factor: 4.099

Review 7.  Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.

Authors:  Hung N Luu; Kristina R Dahlstrom; Patricia Dolan Mullen; Helena M VonVille; Michael E Scheurer
Journal:  Cancer Med       Date:  2013-04-21       Impact factor: 4.452

8.  HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Authors:  Oscar Peralta-Zaragoza; Jessica Deas; Claudia Gómez-Cerón; Wendy Argelia García-Suastegui; Geny Del Socorro Fierros-Zárate; Nadia Judith Jacobo-Herrera
Journal:  Obstet Gynecol Int       Date:  2013-04-14

9.  Use of FTA elute card impregnated with cervicovaginal sample directly into the amplification reaction increases the detection of human papillomavirus DNA.

Authors:  Carla R Santos; Laura G Franciscatto; Regina B Barcellos; Sabrina E M Almeida; Maria Lucia R Rossetti
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.

Authors:  K Haguenoer; S Sengchanh; C Gaudy-Graffin; J Boyard; R Fontenay; H Marret; A Goudeau; N Pigneaux de Laroche; E Rusch; B Giraudeau
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.